HIV Pre-Exposure Prophylaxis Archives - Infectious Disease Advisor

High Prevalence of HCV Infection in MSM Regardless of HIV Status

By

March 11, 2021

The researchers’ objective was to determine the prevalence of HCV antibodies among MSM with and without HIV, as well as factors associated with HCV infection among MSM.

HIV/AIDS

Individuals With Highest HIV Infection Rates Insured by Medicaid Less Likely to Persist With HIV Pre-Exposure Prophylaxis

By

Jessica Nye, PhD

March 2, 2021

Study authors estimated pre-exposure prophylaxis persistence among cohorts of patients with commercial vs Medicaid insurance.

HIV/AIDS

Protection From HIV With Pre-Exposure Prophylaxis May be Accurately Assessed in Urine Samples

By

Jessica Nye, PhD

March 1, 2021

Study authors identified a new tool to support pre-exposure prophylaxis adherence for HIV prevention, primarily in how adequate urine tenofovir levels measured in an immunoassay predicted HIV protection.

HIV/AIDS

Comparing Rates of STIs in Men Before and After Starting HIV PrEP

By

Bradley van Paridon

February 23, 2021

The researchers sought to determine if access to HIV PrEP was associated with preexisting trends in STIs among high-risk men who have sex with men.

HIV/AIDS

Virological Failure on Long-Term Ritonavir-Boosted Darunavir for HIV Not Associated With Acquired DRV Resistance-Associated Mutations

By

Jessica Nye, PhD

February 16, 2021

Study authors described patients with HIV experiencing virological failure while on long-term ritonavir-boosted darunavir therapy.

HIV/AIDS

High Prevalence of Antibiotic Resistance in Men Having Sex with Men

By

Bradley van Paridon

February 11, 2021

The goal of this study was to assess the impact of doxycycline PEP on M genitalium, an emerging pathogen among men who have sex with men that has rising rates of antibiotic resistance.

HIV/AIDS

HIV Patient’s Detectable Viremia Linked to ART-Supplement Interaction

By

Cassandra Pardini, PharmD

February 9, 2021

Prior to pregnancy, her viral load had been undetectable for more than 2 years.

Although sensitivity is an important consideration when deciding among HIV tests, there are other factors to consider, such as test invasiveness, available resources, need for additional studies, and patient adherence.6 Serum- and plasma-based HIV testing is the most invasive and requires the most resources, such as access to a skilled clinician or phlebotomist and access to special equipment (eg, needles, biohazard containers, laboratory). Whole blood testing can be performed by venipuncture or finger-stick. When blood-based tests yield a sufficient specimen sample using venipuncture, additional studies can be undertaken, such as HIV subtyping and assessment for coinfections, including hepatitis or syphilis. In contrast, oral fluid tests do not require special equipment and can be performed in any setting, including at home, providing results in minutes. These tests also eliminate safety and biohazard concerns, such as needlestick injuries and sharps disposal.

HIV/AIDS

HIV Medicine Association of IDSA Publish Updated Guidance on Primary Care for HIV

By

Brandon May

February 5, 2021

The HIV Medicine Association of the Infectious Diseases Society of America published a 2020 update on primary care guidance for persons with HIV.

HIV/AIDS

IAS Panel Releases Updated 2020 Guidelines on ART and HIV Prevention

By

Brandon May

December 4, 2020

The International Antiviral Society published updated 2020 recommendations on use of antiretroviral therapy, laboratory monitoring and screening, prevention, and management of older patients living with HIV.

debunking the patient zero theory of AIDS

HIV/AIDS

PrEP Adherence Lower in Cisgender Women Compared to Cisgender Men

By

Zahra Masoud

November 10, 2020

Investigators sought to determine PrEP adherence in cisgender women compared to cisgender men, transgender women, transgender men, and non-binary patient populations.